

[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
Joseph Schwartz Downgraded (ASND) to Hold and Increased Target to $30 on, Mar 9th, 2017
Joseph Schwartz of Leerink Swann, Downgraded "Ascendis Pharma A/S" (ASND) to Hold and Increased Target from $24 to $30 on, Mar 9th, 2017.
Joseph has made no other calls on ASND in the last 4 months.
There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with Joseph's Rating of Hold.
This is the rating of the analyst that currently disagrees with Joseph
- Alethia Young of "Credit Suisse" Initiated at Buy and Held Target at $28 on, Thursday, February 9th, 2017
Contributing Sources
Similar Stocks and Investing Articles
[ Thu, Mar 02nd 2017
] - WOPRAI
[ Tue, Feb 16th 2016
] - WOPRAI
[ Wed, Jan 20th 2016
] - WOPRAI
[ Tue, Apr 16th 2013
] - WOPRAI
[ Fri, Mar 08th 2013
] - WOPRAI
[ Tue, Mar 05th 2013
] - WOPRAI
[ Wed, Jan 09th 2013
] - WOPRAI
[ Mon, Dec 24th 2012
] - WOPRAI
[ Fri, Nov 09th 2012
] - WOPRAI
[ Fri, Mar 16th 2012
] - WOPRAI